APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nilotinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nilotinib Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchNilotinib Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Nilotinib Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Nilotinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032173 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nilotinib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Nilotinib Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Nilotinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nilotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nilotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nilotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nilotinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nilotinib include Novartis. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nilotinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nilotinib, also provides the sales of main regions and countries. Of the upcoming market potential for Nilotinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nilotinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nilotinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nilotinib sales, projected growth trends, production technology, application and end-user industry.

Nilotinib Segment by Company

Novartis

Nilotinib Segment by Type

50mg

200mg

Other

Nilotinib Segment by Application

Hospital

Drugs Store

Other

Nilotinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nilotinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nilotinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nilotinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nilotinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nilotinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nilotinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nilotinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg Major Manufacturers Table 3. 200mg Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Nilotinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Drugs Store Major Manufacturers Table 8. Other Major Manufacturers Table 9. Nilotinib Industry Trends Table 10. Nilotinib Industry Drivers Table 11. Nilotinib Industry Opportunities and Challenges Table 12. Nilotinib Industry Restraints Table 13. Global Nilotinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Nilotinib Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Nilotinib Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Nilotinib Revenue Market Share by Region (2021-2026) Table 17. Global Nilotinib Revenue Market Share by Region (2027-2032) Table 18. Global Nilotinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Nilotinib Sales by Region (2021-2026) & (k units) Table 20. Global Nilotinib Sales by Region (2027-2032) & (k units) Table 21. Global Nilotinib Sales Market Share by Region (2021-2026) Table 22. Global Nilotinib Sales Market Share by Region (2027-2032) Table 23. Global Nilotinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Nilotinib Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Nilotinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Nilotinib Sales Market Share by Manufacturers (2021-2026) Table 27. Global Nilotinib Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Nilotinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Nilotinib Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Nilotinib Manufacturers, Product Type & Application Table 31. Global Nilotinib Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Nilotinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Nilotinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Nilotinib Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Nilotinib Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Nilotinib Revenue Market Share by Type (2021-2026) Table 38. Global Nilotinib Revenue Market Share by Type (2027-2032) Table 39. Global Nilotinib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Nilotinib Sales by Type (2021-2026) & (k units) Table 41. Global Nilotinib Sales by Type (2027-2032) & (k units) Table 42. Global Nilotinib Sales Market Share by Type (2021-2026) Table 43. Global Nilotinib Sales Market Share by Type (2027-2032) Table 44. Global Nilotinib Price by Type (2021-2026) & (US$/unit) Table 45. Global Nilotinib Price by Type (2027-2032) & (US$/unit) Table 46. Global Nilotinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Nilotinib Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Nilotinib Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Nilotinib Revenue Market Share by Application (2021-2026) Table 50. Global Nilotinib Revenue Market Share by Application (2027-2032) Table 51. Global Nilotinib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Nilotinib Sales by Application (2021-2026) & (k units) Table 53. Global Nilotinib Sales by Application (2027-2032) & (k units) Table 54. Global Nilotinib Sales Market Share by Application (2021-2026) Table 55. Global Nilotinib Sales Market Share by Application (2027-2032) Table 56. Global Nilotinib Price by Application (2021-2026) & (US$/unit) Table 57. Global Nilotinib Price by Application (2027-2032) & (US$/unit) Table 58. Novartis Company Information Table 59. Novartis Business Overview Table 60. Novartis Nilotinib Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Novartis Nilotinib Product Portfolio Table 62. Novartis Recent Development Table 63. North America Nilotinib Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Nilotinib Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Nilotinib Sales by Type (2021-2026) & (k units) Table 66. North America Nilotinib Sales by Type (2027-2032) & (k units) Table 67. North America Nilotinib Sales Price by Type (2021-2026) & (US$/unit) Table 68. North America Nilotinib Sales Price by Type (2027-2032) & (US$/unit) Table 69. North America Nilotinib Revenue by Application (2021-2026) & (US$ Million) Table 70. North America Nilotinib Revenue by Application (2027-2032) & (US$ Million) Table 71. North America Nilotinib Sales by Application (2021-2026) & (k units) Table 72. North America Nilotinib Sales by Application (2027-2032) & (k units) Table 73. North America Nilotinib Sales Price by Application (2021-2026) & (US$/unit) Table 74. North America Nilotinib Sales Price by Application (2027-2032) & (US$/unit) Table 75. North America Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Nilotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 77. North America Nilotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 78. North America Nilotinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 79. North America Nilotinib Sales by Country (2021-2026) & (k units) Table 80. North America Nilotinib Sales by Country (2027-2032) & (k units) Table 81. North America Nilotinib Sales Price by Country (2021-2026) & (US$/unit) Table 82. North America Nilotinib Sales Price by Country (2027-2032) & (US$/unit) Table 83. United States Nilotinib Revenue (2021-2032) & (US$ Million) Table 84. Canada Nilotinib Revenue (2021-2032) & (US$ Million) Table 85. Mexico Nilotinib Revenue (2021-2032) & (US$ Million) Table 86. Europe Nilotinib Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe Nilotinib Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe Nilotinib Sales by Type (2021-2026) & (k units) Table 89. Europe Nilotinib Sales by Type (2027-2032) & (k units) Table 90. Europe Nilotinib Sales Price by Type (2021-2026) & (US$/unit) Table 91. Europe Nilotinib Sales Price by Type (2027-2032) & (US$/unit) Table 92. Europe Nilotinib Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Nilotinib Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Nilotinib Sales by Application (2021-2026) & (k units) Table 95. Europe Nilotinib Sales by Application (2027-2032) & (k units) Table 96. Europe Nilotinib Sales Price by Application (2021-2026) & (US$/unit) Table 97. Europe Nilotinib Sales Price by Application (2027-2032) & (US$/unit) Table 98. Europe Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Nilotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. Europe Nilotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. Europe Nilotinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 102. Europe Nilotinib Sales by Country (2021-2026) & (k units) Table 103. Europe Nilotinib Sales by Country (2027-2032) & (k units) Table 104. Europe Nilotinib Sales Price by Country (2021-2026) & (US$/unit) Table 105. Europe Nilotinib Sales Price by Country (2027-2032) & (US$/unit) Table 106. Germany Nilotinib Revenue (2021-2032) & (US$ Million) Table 107. France Nilotinib Revenue (2021-2032) & (US$ Million) Table 108. U.K. Nilotinib Revenue (2021-2032) & (US$ Million) Table 109. Italy Nilotinib Revenue (2021-2032) & (US$ Million) Table 110. Russia Nilotinib Revenue (2021-2032) & (US$ Million) Table 111. Spain Nilotinib Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Nilotinib Revenue (2021-2032) & (US$ Million) Table 113. Switzerland Nilotinib Revenue (2021-2032) & (US$ Million) Table 114. Sweden Nilotinib Revenue (2021-2032) & (US$ Million) Table 115. Poland Nilotinib Revenue (2021-2032) & (US$ Million) Table 116. China Nilotinib Revenue by Type (2021-2026) & (US$ Million) Table 117. China Nilotinib Revenue by Type (2027-2032) & (US$ Million) Table 118. China Nilotinib Sales by Type (2021-2026) & (k units) Table 119. China Nilotinib Sales by Type (2027-2032) & (k units) Table 120. China Nilotinib Sales Price by Type (2021-2026) & (US$/unit) Table 121. China Nilotinib Sales Price by Type (2027-2032) & (US$/unit) Table 122. China Nilotinib Revenue by Application (2021-2026) & (US$ Million) Table 123. China Nilotinib Revenue by Application (2027-2032) & (US$ Million) Table 124. China Nilotinib Sales by Application (2021-2026) & (k units) Table 125. China Nilotinib Sales by Application (2027-2032) & (k units) Table 126. China Nilotinib Sales Price by Application (2021-2026) & (US$/unit) Table 127. China Nilotinib Sales Price by Application (2027-2032) & (US$/unit) Table 128. Asia Nilotinib Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Nilotinib Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Nilotinib Sales by Type (2021-2026) & (k units) Table 131. Asia Nilotinib Sales by Type (2027-2032) & (k units) Table 132. Asia Nilotinib Sales Price by Type (2021-2026) & (US$/unit) Table 133. Asia Nilotinib Sales Price by Type (2027-2032) & (US$/unit) Table 134. Asia Nilotinib Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Nilotinib Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Nilotinib Sales by Application (2021-2026) & (k units) Table 137. Asia Nilotinib Sales by Application (2027-2032) & (k units) Table 138. Asia Nilotinib Sales Price by Application (2021-2026) & (US$/unit) Table 139. Asia Nilotinib Sales Price by Application (2027-2032) & (US$/unit) Table 140. Asia Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Nilotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Asia Nilotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Asia Nilotinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 144. Asia Nilotinib Sales by Country (2021-2026) & (k units) Table 145. Asia Nilotinib Sales by Country (2027-2032) & (k units) Table 146. Asia Nilotinib Sales Price by Country (2021-2026) & (US$/unit) Table 147. Asia Nilotinib Sales Price by Country (2027-2032) & (US$/unit) Table 148. Japan Nilotinib Revenue (2021-2032) & (US$ Million) Table 149. South Korea Nilotinib Revenue (2021-2032) & (US$ Million) Table 150. India Nilotinib Revenue (2021-2032) & (US$ Million) Table 151. Australia Nilotinib Revenue (2021-2032) & (US$ Million) Table 152. Taiwan Nilotinib Revenue (2021-2032) & (US$ Million) Table 153. Southeast Asia Nilotinib Revenue (2021-2032) & (US$ Million) Table 154. SAMEA Nilotinib Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Nilotinib Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Nilotinib Sales by Type (2021-2026) & (k units) Table 157. SAMEA Nilotinib Sales by Type (2027-2032) & (k units) Table 158. SAMEA Nilotinib Sales Price by Type (2021-2026) & (US$/unit) Table 159. SAMEA Nilotinib Sales Price by Type (2027-2032) & (US$/unit) Table 160. SAMEA Nilotinib Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Nilotinib Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Nilotinib Sales by Application (2021-2026) & (k units) Table 163. SAMEA Nilotinib Sales by Application (2027-2032) & (k units) Table 164. SAMEA Nilotinib Sales Price by Application (2021-2026) & (US$/unit) Table 165. SAMEA Nilotinib Sales Price by Application (2027-2032) & (US$/unit) Table 166. SAMEA Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Nilotinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. SAMEA Nilotinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. SAMEA Nilotinib Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 170. SAMEA Nilotinib Sales by Country (2021-2026) & (k units) Table 171. SAMEA Nilotinib Sales by Country (2027-2032) & (k units) Table 172. SAMEA Nilotinib Sales Price by Country (2021-2026) & (US$/unit) Table 173. SAMEA Nilotinib Sales Price by Country (2027-2032) & (US$/unit) Table 174. Brazil Nilotinib Revenue (2021-2032) & (US$ Million) Table 175. Argentina Nilotinib Revenue (2021-2032) & (US$ Million) Table 176. Chile Nilotinib Revenue (2021-2032) & (US$ Million) Table 177. Colombia Nilotinib Revenue (2021-2032) & (US$ Million) Table 178. Peru Nilotinib Revenue (2021-2032) & (US$ Million) Table 179. Saudi Arabia Nilotinib Revenue (2021-2032) & (US$ Million) Table 180. Israel Nilotinib Revenue (2021-2032) & (US$ Million) Table 181. UAE Nilotinib Revenue (2021-2032) & (US$ Million) Table 182. Turkey Nilotinib Revenue (2021-2032) & (US$ Million) Table 183. Iran Nilotinib Revenue (2021-2032) & (US$ Million) Table 184. Egypt Nilotinib Revenue (2021-2032) & (US$ Million) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Nilotinib Distributors List Table 188. Nilotinib Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Nilotinib Image Figure 2. Global Nilotinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nilotinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg Image Figure 5. 200mg Image Figure 6. Other Image Figure 7. Global Nilotinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Nilotinib Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Drugs Store Image Figure 11. Other Image Figure 12. Global Nilotinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nilotinib Revenue (2021-2032) & (US$ Million) Figure 14. Global Nilotinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Nilotinib Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Nilotinib Revenue Market Share by Region (2021-2032) Figure 17. Global Nilotinib Sales (2021-2032) & (k units) Figure 18. Global Nilotinib Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Nilotinib Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Nilotinib Sales YoY (2021-2032) & (k units) Figure 21. Europe Nilotinib Sales YoY (2021-2032) & (k units) Figure 22. China Nilotinib Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Nilotinib Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Nilotinib Sales YoY (2021-2032) & (k units) Figure 25. Global Nilotinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Nilotinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Nilotinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Nilotinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Nilotinib Revenue Market Share by Type (2021-2032) Figure 31. Global Nilotinib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Nilotinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Nilotinib Sales Market Share by Type (2021-2032) Figure 34. Global Nilotinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Nilotinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Nilotinib Revenue Market Share by Application (2021-2032) Figure 37. Global Nilotinib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Nilotinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Nilotinib Sales Market Share by Application (2021-2032) Figure 40. North America Nilotinib Revenue Share by Type (2021-2032) Figure 41. North America Nilotinib Sales Share by Type (2021-2032) Figure 42. North America Nilotinib Revenue Share by Application (2021-2032) Figure 43. North America Nilotinib Sales Share by Application (2021-2032) Figure 44. North America Nilotinib Revenue Share by Country (2021-2032) Figure 45. North America Nilotinib Sales Share by Country (2021-2032) Figure 46. Europe Nilotinib Revenue Share by Type (2021-2032) Figure 47. Europe Nilotinib Sales Share by Type (2021-2032) Figure 48. Europe Nilotinib Revenue Share by Application (2021-2032) Figure 49. Europe Nilotinib Sales Share by Application (2021-2032) Figure 50. Europe Nilotinib Revenue Share by Country (2021-2032) Figure 51. Europe Nilotinib Sales Share by Country (2021-2032) Figure 52. China Nilotinib Revenue Share by Type (2021-2032) Figure 53. China Nilotinib Sales Share by Type (2021-2032) Figure 54. China Nilotinib Revenue Share by Application (2021-2032) Figure 55. China Nilotinib Sales Share by Application (2021-2032) Figure 56. Asia Nilotinib Revenue Share by Type (2021-2032) Figure 57. Asia Nilotinib Sales Share by Type (2021-2032) Figure 58. Asia Nilotinib Revenue Share by Application (2021-2032) Figure 59. Asia Nilotinib Sales Share by Application (2021-2032) Figure 60. Asia Nilotinib Revenue Share by Country (2021-2032) Figure 61. Asia Nilotinib Sales Share by Country (2021-2032) Figure 62. SAMEA Nilotinib Revenue Share by Type (2021-2032) Figure 63. SAMEA Nilotinib Sales Share by Type (2021-2032) Figure 64. SAMEA Nilotinib Revenue Share by Application (2021-2032) Figure 65. SAMEA Nilotinib Sales Share by Application (2021-2032) Figure 66. SAMEA Nilotinib Revenue Share by Country (2021-2032) Figure 67. SAMEA Nilotinib Sales Share by Country (2021-2032) Figure 68. Nilotinib Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Nilotinib Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 200mg
  • Other
Applications
  • Hospital
  • Drugs Store
  • Other
Companies covered
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nilotinib Market by Type
  3. 1.2.1 Global Nilotinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg
  5. 1.2.3 200mg
  6. 1.2.4 Other
  7. 1.3 Nilotinib Market by Application
  8. 1.3.1 Global Nilotinib Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Drugs Store
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Nilotinib Market Dynamics
  1. 2.1 Nilotinib Industry Trends
  2. 2.2 Nilotinib Industry Drivers
  3. 2.3 Nilotinib Industry Opportunities and Challenges
  4. 2.4 Nilotinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nilotinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nilotinib Revenue by Region
  3. 3.2.1 Global Nilotinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nilotinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Nilotinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Nilotinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nilotinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nilotinib Sales by Region
  9. 3.4.1 Global Nilotinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nilotinib Sales by Region (2021-2026)
  11. 3.4.3 Global Nilotinib Sales by Region (2027-2032)
  12. 3.4.4 Global Nilotinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nilotinib Revenue by Manufacturers
  2. 4.1.1 Global Nilotinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nilotinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nilotinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nilotinib Sales by Manufacturers
  6. 4.2.1 Global Nilotinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nilotinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nilotinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nilotinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nilotinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nilotinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nilotinib Manufacturers, Product Type & Application
  13. 4.7 Global Nilotinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nilotinib Market CR5 and HHI
  16. 4.8.2 2025 Nilotinib Tier 1, Tier 2, and Tier 3
5 Nilotinib Market by Type
  1. 5.1 Global Nilotinib Revenue by Type
  2. 5.1.1 Global Nilotinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nilotinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nilotinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nilotinib Sales by Type
  6. 5.2.1 Global Nilotinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nilotinib Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Nilotinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nilotinib Price by Type
6 Nilotinib Market by Application
  1. 6.1 Global Nilotinib Revenue by Application
  2. 6.1.1 Global Nilotinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nilotinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nilotinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nilotinib Sales by Application
  6. 6.2.1 Global Nilotinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nilotinib Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Nilotinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nilotinib Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Nilotinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Nilotinib Product Portfolio
  6. 7.1.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Nilotinib Market Size by Type
  2. 8.1.1 North America Nilotinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Nilotinib Sales by Type (2021-2032)
  4. 8.1.3 North America Nilotinib Price by Type (2021-2032)
  5. 8.2 North America Nilotinib Market Size by Application
  6. 8.2.1 North America Nilotinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Nilotinib Sales by Application (2021-2032)
  8. 8.2.3 North America Nilotinib Price by Application (2021-2032)
  9. 8.3 North America Nilotinib Market Size by Country
  10. 8.3.1 North America Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nilotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nilotinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Nilotinib Market Size by Type
  2. 9.1.1 Europe Nilotinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nilotinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Nilotinib Price by Type (2021-2032)
  5. 9.2 Europe Nilotinib Market Size by Application
  6. 9.2.1 Europe Nilotinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nilotinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Nilotinib Price by Application (2021-2032)
  9. 9.3 Europe Nilotinib Market Size by Country
  10. 9.3.1 Europe Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nilotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nilotinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Nilotinib Market Size by Type
  2. 10.1.1 China Nilotinib Revenue by Type (2021-2032)
  3. 10.1.2 China Nilotinib Sales by Type (2021-2032)
  4. 10.1.3 China Nilotinib Price by Type (2021-2032)
  5. 10.2 China Nilotinib Market Size by Application
  6. 10.2.1 China Nilotinib Revenue by Application (2021-2032)
  7. 10.2.2 China Nilotinib Sales by Application (2021-2032)
  8. 10.2.3 China Nilotinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nilotinib Market Size by Type
  2. 11.1.1 Asia Nilotinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nilotinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Nilotinib Price by Type (2021-2032)
  5. 11.2 Asia Nilotinib Market Size by Application
  6. 11.2.1 Asia Nilotinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nilotinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Nilotinib Price by Application (2021-2032)
  9. 11.3 Asia Nilotinib Market Size by Country
  10. 11.3.1 Asia Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nilotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nilotinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nilotinib Market Size by Type
  2. 12.1.1 SAMEA Nilotinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nilotinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nilotinib Price by Type (2021-2032)
  5. 12.2 SAMEA Nilotinib Market Size by Application
  6. 12.2.1 SAMEA Nilotinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nilotinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nilotinib Price by Application (2021-2032)
  9. 12.3 SAMEA Nilotinib Market Size by Country
  10. 12.3.1 SAMEA Nilotinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nilotinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nilotinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nilotinib Value Chain Analysis
  2. 13.1.1 Nilotinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nilotinib Production Mode & Process
  6. 13.2 Nilotinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nilotinib Distributors
  9. 13.2.3 Nilotinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst